Constellation Pharmaceuticals, Inc.
CNST
CNST was delisted on the 14th of July, 2021.
131 hedge funds and large institutions have $1.22B invested in Constellation Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 17 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 42
2% less funds holding
Funds holding: 134 → 131 (-3)
17% less capital invested
Capital invested by funds: $1.46B → $1.22B (-$244M)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
39% less call options, than puts
Call options by funds: $4.39M | Put options by funds: $7.23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$16.3M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$12.7M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.63M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$8.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$22.7M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$10.6M |
| 3 |
Millennium Management
New York
|
-$9.78M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.34M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.62M |
CNST Hedge Fund Activity: Q1 2021 in Review
131 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q1 2021, worth a combined $1.22B — down 17% from $1.46B a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CNST and 14 opened new positions — a net loss of 3 holders — while 42 trimmed existing stakes and 49 added.
The largest buyer was State Street, adding an estimated $16.3M. The largest seller was Polar Capital Holdings, cutting an estimated $22.7M.
- 131 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q1 2021, down from 134 in Q4 2020.
- Funds reported $1.22B of Constellation Pharmaceuticals, Inc. stock for Q1 2021, down 17% quarter-over-quarter.
- 14 funds opened new Constellation Pharmaceuticals, Inc. positions in Q1 2021 and 17 closed out, a net change of -3 holders.
- The largest Constellation Pharmaceuticals, Inc. buyer in Q1 2021 was State Street, an estimated $16.3M added.
- The largest Constellation Pharmaceuticals, Inc. seller in Q1 2021 was Polar Capital Holdings, an estimated $22.7M sold.
Based on aggregated 13F filings for Q1 2021.